MyFinsight
Home
About
Contact
Back
Income Statement
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
source: myfinsight.com
Download
Download image
Net loss
-$775,673
(23.27%↑ Y/Y)
Foreign currency gain
$581
(267.72%↑ Y/Y)
Interest income
$365
(-83.65%↓ Y/Y)
Interest expense
$1,810
(-56.43%↓ Y/Y)
Loss from operations
-$774,809
(23.22%↑ Y/Y)
Total costs and
expenses
$774,809
(-23.22%↓ Y/Y)
General and
administrative costs
$714,161
(133.12%↑ Y/Y)
Research and development
costs
$60,648
(-71.22%↓ Y/Y)
Back